MTFP1 and cancer: The authors further concluded that uncoupling MTFP1 levels from the TORC1/4E-BP pathway after mTOR inhibition blocks the hyperfusion status and leads to apoptosis, thereby offering a new therapeutic opportunity for these type of anti-cancer drugs, converting them from cytostatic to cytotoxic [107].